OBJECTIVE: To assess the presence of microbial DNA in the blood by polymerase chain reaction (PCR) and its association with disease severity and markers of inflammation in severe sepsis and to compare the performance of PCR with blood culture (BC). DESIGN: Prospective multicentric controlled observational study. SETTING: Three surgical intensive care units in university centers and large teaching hospitals. PATIENTS: One hundred forty-two patients with severe sepsis and 63 surgical controls. INTERVENTIONS: Presence of microbial DNA was assessed by multiplex PCR upon enrollment, and each time a BC was obtained. MEASUREMENTS AND MAIN RESULTS: Controls had both approximately 4% positive PCRs and BCs. In severe sepsis, 34.7% of PCRs were positive compared to 16.5% of BCs (P < 0.001). Consistently, 70.3% of BCs had a corresponding PCR result, while only 21.4% of PCR results were confirmed by BC. Compared to patients with negative PCRs at enrollment, those testing positive had higher organ dysfunction scores [SOFA, median (25th-75th percentile) 12 (7-15) vs. 9 (7-11); P = 0.023] and a trend toward higher mortality (PCR negative 25.3%; PCR positive 39.1%; P = 0.115). CONCLUSIONS: In septic patients, concordance between BC and PCR is moderate. However, PCR-based pathogen detection correlated with disease severity even if the BC remained negative, suggesting that presence of microbial DNA in the bloodstream is a significant event. The clinical utility to facilitate treatment decisions warrants investigation.
OBJECTIVE: To assess the presence of microbial DNA in the blood by polymerase chain reaction (PCR) and its association with disease severity and markers of inflammation in severe sepsis and to compare the performance of PCR with blood culture (BC). DESIGN: Prospective multicentric controlled observational study. SETTING: Three surgical intensive care units in university centers and large teaching hospitals. PATIENTS: One hundred forty-two patients with severe sepsis and 63 surgical controls. INTERVENTIONS: Presence of microbial DNA was assessed by multiplex PCR upon enrollment, and each time a BC was obtained. MEASUREMENTS AND MAIN RESULTS: Controls had both approximately 4% positive PCRs and BCs. In severe sepsis, 34.7% of PCRs were positive compared to 16.5% of BCs (P < 0.001). Consistently, 70.3% of BCs had a corresponding PCR result, while only 21.4% of PCR results were confirmed by BC. Compared to patients with negative PCRs at enrollment, those testing positive had higher organ dysfunction scores [SOFA, median (25th-75th percentile) 12 (7-15) vs. 9 (7-11); P = 0.023] and a trend toward higher mortality (PCR negative 25.3%; PCR positive 39.1%; P = 0.115). CONCLUSIONS: In septic patients, concordance between BC and PCR is moderate. However, PCR-based pathogen detection correlated with disease severity even if the BC remained negative, suggesting that presence of microbial DNA in the bloodstream is a significant event. The clinical utility to facilitate treatment decisions warrants investigation.
Authors: Rodger D MacArthur; Mark Miller; Timothy Albertson; Edward Panacek; David Johnson; Leah Teoh; William Barchuk Journal: Clin Infect Dis Date: 2003-12-22 Impact factor: 9.079
Authors: Harald J van Loon; Menno R Vriens; Ad C Fluit; Annet Troelstra; Christiaan van der Werken; Jan Verhoef; Marc J M Bonten Journal: Am J Respir Crit Care Med Date: 2004-10-29 Impact factor: 21.405
Authors: H M Blumberg; W R Jarvis; J M Soucie; J E Edwards; J E Patterson; M A Pfaller; M S Rangel-Frausto; M G Rinaldi; L Saiman; R T Wiblin; R P Wenzel Journal: Clin Infect Dis Date: 2001-06-20 Impact factor: 9.079
Authors: S Bauer; C J Kirschning; H Häcker; V Redecke; S Hausmann; S Akira; H Wagner; G B Lipford Journal: Proc Natl Acad Sci U S A Date: 2001-07-24 Impact factor: 11.205
Authors: H Westh; G Lisby; F Breysse; B Böddinghaus; M Chomarat; V Gant; A Goglio; A Raglio; H Schuster; F Stuber; H Wissing; A Hoeft Journal: Clin Microbiol Infect Date: 2009-04-21 Impact factor: 8.067
Authors: Richard F Louie; Zuping Tang; Timothy E Albertson; Stuart Cohen; Nam K Tran; Gerald J Kost Journal: Crit Care Med Date: 2008-05 Impact factor: 7.598
Authors: S Hettwer; J Wilhelm; M Schürmann; H Ebelt; D Hammer; M Amoury; F Hofmann; A Oehme; D Wilhelms; A S Kekulé; T Klöss; K Werdan Journal: Med Klin Intensivmed Notfmed Date: 2012-02 Impact factor: 0.840
Authors: M Bernhard; G Marx; K Weismüller; C Lichtenstern; K Mayer; F M Brunkhorst; M A Weigand Journal: Anaesthesist Date: 2010-05 Impact factor: 1.041